Log in to save to my catalogue

Gene therapy for alopecia in type II rickets model rats using vitamin D receptor-expressing adenovir...

Gene therapy for alopecia in type II rickets model rats using vitamin D receptor-expressing adenovir...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ff036fc97d624357a3c28fab11ccd90d

Gene therapy for alopecia in type II rickets model rats using vitamin D receptor-expressing adenovirus vector

About this item

Full title

Gene therapy for alopecia in type II rickets model rats using vitamin D receptor-expressing adenovirus vector

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2023-10, Vol.13 (1), p.18528-18528, Article 18528

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Type II rickets is a hereditary disease caused by a mutation in the vitamin D receptor (VDR) gene. The main symptoms of this disease are bone dysplasia and alopecia. Bone dysplasia can be ameliorated by high calcium intake; however, there is no suitable treatment for alopecia. In this study, we verified whether gene therapy using an adenoviral vect...

Alternative Titles

Full title

Gene therapy for alopecia in type II rickets model rats using vitamin D receptor-expressing adenovirus vector

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ff036fc97d624357a3c28fab11ccd90d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ff036fc97d624357a3c28fab11ccd90d

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-023-45594-2

How to access this item